Screener
BridgeBio Pharma BBIO Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
Based on trailing twelve months.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's gross margin?
- BridgeBio Pharma (BBIO) reported gross margin of 95.1% in Q1 2026.
- How has BridgeBio Pharma's gross margin changed year-over-year?
- BridgeBio Pharma's gross margin decreased by 0.2% year-over-year, from 95.4% to 95.1%.
- What is the long-term trend for BridgeBio Pharma's gross margin?
- Over 4 years (2021 to 2025), BridgeBio Pharma's gross margin has grown at a -0.1% compound annual growth rate (CAGR), from 96.1% to 95.8%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about BridgeBio Pharma's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude